title: First-line therapy for mCRC - the influence of primary tumour location on the therapeutic algorithm.
authors.affiliation: Unit of Medical Oncology 2, Azienda Ospedaliera-Universitaria Pisana; and at the Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma, 67, 56126 Pisa, Italy.
authors.forename: Chiara
authors.initials: C
authors.lastname: Cremolini
authors.affiliation: Unit of Medical Oncology 2, Azienda Ospedaliera-Universitaria Pisana; and at the Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma, 67, 56126 Pisa, Italy.
authors.forename: Carlotta
authors.initials: C
authors.lastname: Antoniotti
authors.affiliation: Unit of Medical Oncology 2, Azienda Ospedaliera-Universitaria Pisana; and at the Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma, 67, 56126 Pisa, Italy.
authors.forename: Roberto
authors.initials: R
authors.lastname: Moretto
authors.affiliation: Unit of Medical Oncology 2, Azienda Ospedaliera-Universitaria Pisana; and at the Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma, 67, 56126 Pisa, Italy.
authors.forename: Gianluca
authors.initials: G
authors.lastname: Masi
authors.affiliation: Unit of Medical Oncology 2, Azienda Ospedaliera-Universitaria Pisana; and at the Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma, 67, 56126 Pisa, Italy.
authors.forename: Alfredo
authors.initials: A
authors.lastname: Falcone
mesh_terms: D000465:Algorithms; D000068258:Bevacizumab; D015179:Colorectal Neoplasms; D006801:Humans
chemical_list: D000068258:Bevacizumab